Photocure $PHO.OL boost on chinese partnership deal

Photocure PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200.

Press release
https://photocure.com/news/photocure-and-asieris-enter-into-a-global-licensing-deal-for-cevira-with-up-to-usd-250-million-in-milestones-and-double-digit-royalties/